The U.S. Food and Drug Administration (FDA) has warned the public that the atypical antipsychotic drug olanzapine pamoate—sold under the brand name Zyprexa Relprevv—might have caused sudden deaths in patients.
What Is Zyprexa Relprevv? When Is It Prescribed?
Zyprexa is made by Eli Lilly and Co. The FDA approved the drug as a tablet in 1996, but Zyprexa Relprevv, which is the long-lasting, intramuscular injection form of the drug, wasn’t approved until 2009. This version of Zyprexa is indicated only for treating symptoms of schizophrenia and bipolar disorder.
“Atypical” antipsychotic drugs like Zyprexa are believed to block dopamine receptors in the brain, but unlike earlier antipsychotic drugs, they don’t cause involuntary body movements that can persist after ceasing use.
Zyprexa Relprevv Might Cause Sudden Death
On June 18, 2013, the FDA published a safety announcement informing the public that it was investigating two sudden deaths of users of Zyprexa Relprevv. Both patients died three to four days after receiving the drug, which is long after the mandatory three-hour monitoring period designed to ensure that negative side effects related to the intramuscular injection don’t materialize. Both patients’ blood contained high concentrations of olanzapine, which can be dangerous and leads to the following symptoms:
- Cardiopulmonary arrest
- Cardiac arrhythmias
- Reduced level of consciousness ranging from sedation to coma
RLG’s Lawyers Will Make Things Easier
The process of demanding compensation for the harm you’ve suffered can be complicated, even if it doesn’t seem fair that you should have to go through even more trouble to be made whole again. The lawyers at the Rottenstein Law Group believe that obtaining legal satisfaction from those who harmed you shouldn’t require more hardship. That’s why we do everything we can to streamline the process, and we will file a Zyprexa Relprevv lawsuit on your behalf if necessary.
If you or a loved one has taken Zyprexa Relprevv, and you believe it caused an injury, contact RLG today.